Medicare OK clears sales hurdle for heart surgery simulation software
Medicare will now reimburse nearly $1,000 per procedure for heart surgery planning software from an Ohio State University spinoff – clearing a hurdle for increasing sales to hospitals. Dasi Simulations LLC’s software – “3D predictive model generation for preplanning of... Read More →
Teijin Limited Signs Joint R&D Agreement with Garwood Medical Devices
Electrochemical therapeutic technology BioPrax™ addresses the high failure rate of joint implants due to infection BUFFALO, NY, UNITED STATES, January 3, 2024 /EINPresswire.com/ — Garwood Medical Devices, a breakthrough New York medtech company, and Teijin Limited, a leading Japanese conglomerate... Read More →
Galway medtech breakthrough firm SymPhysis raises €1.5m
SymPhysis Medical has received €1.5m in funding and is seeking an additional €4.5m-plus early next year to support the continued development of its breakthrough medical device, FDA approval and the creation of new jobs. The Galway business is developing a... Read More →
Sentante Secures €6 Million in New Funding to Revolutionize Endovascular Care
Sentante, a pioneering medical device company headquartered in Lithuania, announces the closing of a €6 Million seed funding round led by Practica Capital with participation of EIC fund. The company will use the proceeds from the financing for the planned... Read More →
GT Medical enhances GammaTile Therapy with Cesium-131 seed business acquisition from Isoray Medical
USA —GT Medical Technologies, a US-based medical equipment manufacturer, has agreed to acquire the radioactive Cesium-131 seed business and its infrastructure from Isoray Medical, a subsidiary of Perspective Therapeutics. This acquisition aims to fortify GT Medical’s position in the market,... Read More →
Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders
SAN FRANCISCO–(BUSINESS WIRE)– Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing round led by Khosla Ventures, with participation from Y Combinator. Read More
Gravitas Medical Inc. Announces SECOND FDA Breakthrough Device Designation for its Entarik System; Pediatric Patients to Benefit from Enteral Nutrition Innovation!
Gravitas Medical to accelerate development and approval processes to expedite pediatric patient access to Entarik’s revolutionary technology. SAN FRANCISCO, Dec. 13, 2023 /PRNewswire-PRWeb/ — Gravitas Medical Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has... Read More →
Xpan secures FDA 510(k) clearance and announces successful completion of initial human clinical cases in the United States
The XpanTM Universal Trocar System is a first of its kind, radially expanding trocar that can be tailored by surgeons during laparoscopic procedures to accommodate 3 mm up to 12 mm instruments TORONTO–(BUSINESS WIRE)–Xpan Inc., a medical device company focused... Read More →
Vivante’s GIThrive Becomes First Digestive Health Platform Selected for The Evernorth Digital Health Formulary
CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) — Digital digestive health solution provider Vivante Health today announced the addition of its GIThrive solution to the Evernorth Digital Health Formulary, which connects employers, insurers, and customers with innovative, affordable, and evidence-based care... Read More →
Movn Health Selected as Winner of Point32Health’s Second Innovation Challenge
CANTON, Mass., Dec. 12, 2023 /PRNewswire/ — Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has announced Movn Health as the winner of its second annual Innovation Challenge. Based in Irvine, California, Movn Health is... Read More →